Translationally Controlled Tumor Protein (TCTP) and Growth Regulation in the Drosophila Model

Kwang-Wook Choi1, Sung-Tae Hong2

  • 1Department of Biological Sciences, Korea Advanced Institute of Science & Technology, Daejeon, Republic of Korea. kchoi100@kaist.ac.kr.

Insights

Translationally controlled tumor protein (TCTP) is key in reverting cancer cells. Drosophila studies reveal TCTP

Area of Science:

  • Cancer Biology
  • Genetics
  • Molecular Biology

Background:

  • Translationally controlled tumor protein (TCTP) is implicated in tumor reversion.
  • The genetic networks and precise roles of TCTP in cancer remain incompletely understood.
  • Model organisms offer insights into TCTP functions in normal and cancerous cells.

Purpose of the Study:

  • To investigate the in vivo functions of TCTP using genetic analysis in Drosophila.
  • To elucidate the genetic and molecular interactions of Tctp with key cellular pathways.
  • To highlight Drosophila as a model for studying TCTP in growth control and tumor reversion.

Main Methods:

  • Genetic analysis in Drosophila.
  • Studies on Tctp interactions with growth signaling, DNA repair, and epigenetic regulators.
  • Observation of Tctp's role in tissue growth, cell death, and genome stability.

Main Results:

  • Tctp plays diverse roles in Drosophila, including regulating tissue growth, cell death, genome stability, and chromatin organization.
  • Silencing Tctp in Drosophila suppresses tumorous growth, mirroring human TCTP's role.
  • Identified specific genetic and molecular partners of Tctp involved in critical cellular processes.

Conclusions:

  • Drosophila serves as an effective model for dissecting TCTP functions in cancer biology.
  • Understanding Tctp interactions is crucial for developing strategies for tumor reversion.
  • Further research in Drosophila can illuminate TCTP's role in both normal development and cancer progression.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.0K